ZLAB Zai Lab Ltd

Price (delayed)

$163.86

Market cap

$14.52B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.46

Enterprise value

$14.09B

Sector: Healthcare
Industry: Biotechnology

Highlights

The quick ratio has soared by 104% year-on-year
The debt has contracted by 15% YoY
The company's net income fell by 38% YoY
The EPS has contracted by 14% YoY

Key stats

What are the main financial stats of ZLAB
Market
Shares outstanding
88.59M
Market cap
$14.52B
Enterprise value
$14.09B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.35
Price to sales (P/S)
259.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
287.86
Earnings
Revenue
$48.96M
EBIT
-$268.72M
EBITDA
-$259.77M
Free cash flow
-$226.19M
Per share
EPS
-$3.46
Free cash flow per share
-$2.91
Book value per share
$15.83
Revenue per share
$0.63
TBVPS
$16.59
Balance sheet
Total assets
$1.3B
Total liabilities
$128.29M
Debt
$18.6M
Equity
$1.17B
Working capital
$1.12B
Liquidity
Debt to equity
0.02
Current ratio
12.4
Quick ratio
12.1
Net debt/EBITDA
1.63
Margins
EBITDA margin
-530.6%
Gross margin
65.8%
Net margin
-549.3%
Operating margin
-557.1%
Efficiency
Return on assets
-32.5%
Return on equity
-36.7%
Return on invested capital
-53.1%
Return on capital employed
-22.4%
Return on sales
-548.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZLAB stock price

How has the Zai Lab stock price performed over time
Intraday
-0.26%
1 week
24.09%
1 month
23.7%
1 year
158.17%
YTD
21.07%
QTD
22.81%

Financial performance

How have Zai Lab's revenue and profit performed over time
Revenue
$48.96M
Gross profit
$32.22M
Operating income
-$272.73M
Net income
-$268.91M
Gross margin
65.8%
Net margin
-549.3%
The company's operating margin has surged by 64% YoY
The net margin has soared by 63% YoY
The company's net income fell by 38% YoY
Zai Lab's operating income has decreased by 35% YoY

Growth

What is Zai Lab's growth rate over time

Valuation

What is Zai Lab stock price valuation
P/E
N/A
P/B
10.35
P/S
259.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
287.86
The EPS has contracted by 14% YoY
The stock's P/B is 21% above its last 4 quarters average of 8.6

Efficiency

How efficient is Zai Lab business performance
The ROS has soared by 63% YoY
ZLAB's ROE is up by 49% YoY
The ROA has grown by 45% YoY
Zai Lab's return on invested capital has increased by 40% YoY

Dividends

What is ZLAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ZLAB.

Financial health

How did Zai Lab financials performed over time
The company's total liabilities has surged by 112% YoY
The quick ratio has soared by 104% year-on-year
The debt is 98% less than the equity
Zai Lab's debt to equity has plunged by 71% YoY
The debt has contracted by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.